BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26745751)

  • 1. Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer.
    Mizuno A; Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Dig Surg; 2016; 33(2):121-8. PubMed ID: 26745751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer.
    Kanda M; Kobayashi D; Tanaka C; Iwata N; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Murotani K; Fujiwara M; Kodera Y
    Gastric Cancer; 2016 Jan; 19(1):255-63. PubMed ID: 25563579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Number of retrieved lymph nodes is an independent prognostic factor after total gastrectomy for patients with stage III gastric cancer: propensity score matching analysis of a multi-institution dataset.
    Hayashi S; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    Gastric Cancer; 2019 Jul; 22(4):853-863. PubMed ID: 30483985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative.
    Squires MH; Kooby DA; Poultsides GA; Weber SM; Bloomston M; Fields RC; Pawlik TM; Votanopoulos KI; Schmidt CR; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Levine EA; Jin LX; Cho CS; Winslow ER; Russell MC; Staley CA; Maithel SK
    J Am Coll Surg; 2015 Sep; 221(3):767-77. PubMed ID: 26228017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset.
    Ito Y; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    World J Surg; 2019 Mar; 43(3):870-877. PubMed ID: 30377722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
    Wang J; Yu JC; Kang WM; Ma ZQ
    J Surg Oncol; 2012 Mar; 105(4):400-4. PubMed ID: 22311818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative blood loss does not independently affect the survival outcome of gastric cancer patients who underwent curative resection.
    Zhao B; Huang X; Lu H; Zhang J; Luo R; Xu H; Huang B
    Clin Transl Oncol; 2019 Sep; 21(9):1197-1206. PubMed ID: 30689183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer.
    Son T; Hyung WJ; Lee JH; Kim YM; Kim HI; An JY; Cheong JH; Noh SH
    Cancer; 2012 Oct; 118(19):4687-93. PubMed ID: 22415925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there an optimal surgery time after endoscopic resection in early gastric cancer?
    Kim MJ; Kim JH; Lee YC; Kim JW; Choi SH; Hyung WJ; Noh SH; Youn YH; Park H; Lee SI
    Ann Surg Oncol; 2014 Jan; 21(1):232-9. PubMed ID: 24100960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative risk assessment for gastrectomy by surgical apgar score.
    Miki Y; Tokunaga M; Tanizawa Y; Bando E; Kawamura T; Terashima M
    Ann Surg Oncol; 2014 Aug; 21(8):2601-7. PubMed ID: 24664626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
    Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
    Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
    J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer.
    Zhang CD; Shen MY; Zhang JK; Ning FL; Zhou BS; Dai DQ
    Sci Rep; 2015 Nov; 5():17273. PubMed ID: 26602830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
    Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.